Analyst Activity – Seaport Global Securities Initiates Coverage On NASDAQ:INFI – Infinity Pharmaceuticals (NASDAQ:INFI) With a Buy

ME Staff
-
0

Analyst Ratings For NASDAQ:INFI – Infinity Pharmaceuticals (NASDAQ:INFI)

Today, Seaport Global Securities initiated coverage on NASDAQ:INFI – Infinity Pharmaceuticals (NASDAQ:INFI) with a Buy.

Some recent analyst ratings include

  • 5/31/2018-Seaport Global Securities initiated coverage with a Buy rating.
  • 10/12/2017-Wells Fargo & Co Upgrade from a “Market Perform ➝ Outperform” rating to a “” rating.
  • 11/10/2016-JPMorgan Chase & Co. Reiterated Rating of Hold.
  • 8/11/2016-Morgan Stanley Reiterated Rating of Hold.
  • 8/10/2016-FBR & Co Reiterated Rating of Hold.
  • 8/9/2016-Wedbush Reiterated Rating of Neutral.
  • 6/15/2016-Jefferies Group was Downgraded by analysts at Jefferies Group from a “Buy ➝ Hold” rating to a “” rating.

Recent Insider Trading Activity For NASDAQ:INFI – Infinity Pharmaceuticals (NASDAQ:INFI)
NASDAQ:INFI – Infinity Pharmaceuticals (NASDAQ:INFI) has insider ownership of 11.45% and institutional ownership of 50.55%.

  • On 4/10/2018 Value Fund L P Biotechnology, Major Shareholder, bought 1,510,000 with an average share price of $1.97 per share and the total transaction amounting to $2,974,700.00.
  • On 3/5/2018 Adelene Q Perkins, CEO, sold 5,000 with an average share price of $2.78 per share and the total transaction amounting to $13,900.00.
  • On 12/6/2017 Lawrence E Bloch, President, bought 500,000 with an average share price of $1.81 per share and the total transaction amounting to $905,000.00.
  • On 10/4/2017 Value Fund L P Biotechnology, Insider, bought 1,600,046 with an average share price of $1.26 per share and the total transaction amounting to $2,016,057.96.
  • On 3/17/2017 Michael C Venuti, Director, sold 6,250 with an average share price of $3.48 per share and the total transaction amounting to $21,750.00.
  • On 1/3/2017 Value Fund L P Biotechnology, Major Shareholder, bought 4,379 with an average share price of $1.34 per share and the total transaction amounting to $5,867.86.
  • On 12/30/2016 Value Fund L P Biotechnology, Major Shareholder, bought 742,401 with an average share price of $1.34 per share and the total transaction amounting to $994,817.34.

Recent Trading Activity for NASDAQ:INFI – Infinity Pharmaceuticals (NASDAQ:INFI)
Shares of NASDAQ:INFI – Infinity Pharmaceuticals closed the previous trading session at 2.05 up +0.05 2.50% with shares trading hands.